Holen Sie sich die Stockscreener-App
1.54
3.14%
-0.05
Schlusskurs vom Vortag:
$1.59
Offen:
$1.6
24-Stunden-Volumen:
1.20M
Relative Volume:
1.53
Marktkapitalisierung:
$122.79M
Einnahmen:
$63.63M
Nettoeinkommen (Verlust:
$10.62M
KGV:
30.80
EPS:
0.05
Netto-Cashflow:
$-8.64M
1W Leistung:
-0.65%
1M Leistung:
+8.45%
6M Leistung:
-35.02%
1J Leistung:
+50.98%
1-Tages-Spanne:
$1.5201
$1.60
1-Wochen-Bereich:
$1.5201
$1.6872
52-Wochen-Spanne:
$0.98
$3.10
Protalix BioTherapeutics Inc. Stock (PLX) Company Profile
Firmenname
Protalix BioTherapeutics Inc.
Sektor
Branche
Telefon
972 4 988 9488
Adresse
2 Snunit Street, Science Park PO Box 455, Karmiel
Vergleichen Sie PLX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PLX
Protalix BioTherapeutics Inc.
|
1.54 | 126.77M | 63.63M | 10.62M | -8.64M | 0.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Protalix BioTherapeutics Inc. Stock (PLX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-06-08 | Bestätigt | H.C. Wainwright | Buy |
| 2017-04-17 | Bestätigt | Rodman & Renshaw | Buy |
| 2016-04-04 | Eingeleitet | Rodman & Renshaw | Buy |
| 2015-04-23 | Hochstufung | Jefferies | Hold → Buy |
| 2014-11-12 | Bestätigt | R. F. Lafferty | Buy |
| 2014-01-24 | Eingeleitet | R. F. Lafferty | Buy |
| 2012-05-02 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2012-05-02 | Bestätigt | Oppenheimer | Outperform |
| 2012-04-30 | Herabstufung | Auriga | Buy → Hold |
| 2011-10-13 | Eingeleitet | Morgan Joseph | Hold |
| 2011-03-17 | Herabstufung | WBB Securities | Strong Buy → Buy |
| 2010-11-09 | Bestätigt | Oppenheimer | Outperform |
| 2010-10-14 | Bestätigt | UBS | Buy |
| 2009-12-02 | Bestätigt | Hapoalim | Outperform |
| 2009-09-22 | Eingeleitet | Canaccord Adams | Buy |
| 2009-09-02 | Eingeleitet | Hapoalim | Outperform |
| 2008-12-01 | Bestätigt | Oppenheimer | Outperform |
| 2008-03-11 | Eingeleitet | UBS | Buy |
| 2007-11-20 | Eingeleitet | CIBC Wrld Mkts | Sector Outperform |
Alle ansehen
Protalix BioTherapeutics Inc. Aktie (PLX) Neueste Nachrichten
Will Protalix BioTherapeutics Inc. price bounce be sustainableWeekly Profit Recap & Weekly Breakout Watchlists - Newser
Why Protalix BioTherapeutics Inc. is moving today2025 Market Trends & Long-Term Growth Stock Strategies - Newser
What indicators show strength in Protalix BioTherapeutics Inc.July 2025 Action & High Accuracy Trade Signal Alerts - Newser
Volume spikes in Protalix BioTherapeutics Inc. stock – what they mean2025 Macro Impact & Fast Entry Momentum Alerts - Newser
Can Protalix BioTherapeutics Inc. weather a recessionJuly 2025 PostEarnings & Entry Point Strategy Guides - خودرو بانک
What’s next for Protalix BioTherapeutics Inc. stock priceBear Alert & Momentum Based Trading Ideas - Newser
Trend analysis for Protalix BioTherapeutics Inc. this weekJuly 2025 Price Swings & Reliable Breakout Forecasts - Newser
Analyzing net buyer seller activity in Protalix BioTherapeutics Inc.Earnings Trend Report & Daily Technical Stock Forecast Reports - Newser
Is Protalix BioTherapeutics Inc. stock bottoming outTrade Analysis Report & Risk Managed Investment Signals - Newser
Price momentum metrics for Protalix BioTherapeutics Inc. explainedWeekly Investment Report & Verified Swing Trading Watchlist - Newser
Using R and stats models for Protalix BioTherapeutics Inc. forecastingWeekly Investment Summary & High Accuracy Swing Trade Signals - Newser
Pattern recognition hints at Protalix BioTherapeutics Inc. upsideJuly 2025 PostEarnings & Technical Confirmation Alerts - Newser
Using data tools to time your Protalix BioTherapeutics Inc. exit2025 Bull vs Bear & Stock Portfolio Risk Control - Newser
What recovery options are there for Protalix BioTherapeutics Inc.July 2025 Trade Ideas & AI Based Buy and Sell Signals - Newser
Is it time to cut losses on Protalix BioTherapeutics Inc.Weekly Trading Summary & Fast Entry Momentum Trade Alerts - Newser
Backtesting results for Protalix BioTherapeutics Inc. trading strategiesGold Moves & Capital Efficiency Focused Strategies - Newser
Best data tools to analyze Protalix BioTherapeutics Inc. stock2025 Analyst Calls & Consistent Growth Equity Picks - Newser
Can a trend reversal in Protalix BioTherapeutics Inc. lead to recoveryPortfolio Update Summary & Daily Stock Momentum Reports - Newser
Historical volatility pattern of Protalix BioTherapeutics Inc. visualizedDay Trade & Real-Time Price Movement Reports - Newser
Is Protalix BioTherapeutics Inc. stock a buy or sellWeekly Trend Report & Growth Focused Stock Reports - خودرو بانک
Protalix Biotherapeutics shares rise 5.81% intraday after CEO to present at H.C. Wainwright conference. - AInvest
Protalix BioTherapeutics' CEO to present at H.C. Wainwright conference. - AInvest
Plant-Based Protein Therapy Pioneer Protalix BioTherapeutics to Showcase at Global Investment Event - Stock Titan
Is Protalix BioTherapeutics Inc. attractive at current valuation2025 Earnings Impact & Daily Chart Pattern Signals - خودرو بانک
Why Protalix BioTherapeutics Inc. stock attracts strong analyst attentionMarket Performance Report & Precise Buy Zone Tips - Newser
Is Protalix BioTherapeutics Inc. a strong candidate for buy and holdQuarterly Trade Summary & Free Reliable Trade Execution Plans - خودرو بانک
Protalix BioTherapeutics Q2 Earnings Call: Robust Growth Amid Challenges - AInvest
Protalix BioTherapeutics : PLX Corporate Presentation (August 2025) - MarketScreener
Forecasting Protalix BioTherapeutics Inc. price range with options dataDay Trade & Smart Allocation Stock Reports - Newser
What machine learning models say about Protalix BioTherapeutics Inc.July 2025 EndofMonth & Intraday High Probability Alerts - Newser
Protalix BioTherapeutics Reports Robust Growth Amid Challenges - TipRanks
Will Protalix BioTherapeutics Inc. bounce back from current support2025 Historical Comparison & Free Expert Approved Momentum Trade Ideas - Newser
Analyzing Protalix BioTherapeutics Inc. with multi timeframe chartsCPI Data & Capital Protection Trade Alerts - Newser
Applying sector rotation models to Protalix BioTherapeutics Inc.Trend Reversal & High Accuracy Buy Signal Tips - Newser
Finanzdaten der Protalix BioTherapeutics Inc.-Aktie (PLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):